Physician profile
Neda Gioia
NPI 1063584738
$12,776.93
in general payments reported to CMS, 2019-2025
9 companies · $5,779 in 2025
The $5,779 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $52.62 · 2022: $65.92 · 2023: $275 · 2024: $6,229 · 2025: $5,779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $628 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,155.00 |
| Food and Beverage | $628.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $11,597.62 | 2023-2025 | Blink Nutritears, Infuse |
| Heru, INC. | $500.00 | 2025 | Heru Hmd |
| Johnson & Johnson Vision Care, INC. | $284.20 | 2019-2022 | |
| Coopervision INC. | $108.34 | 2019 | |
| Sight Sciences, INC. | $85.96 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $83.11 | 2025 | Xdemvy |
| Dompe US, INC. | $72.97 | 2025 | Oxervate |
| Lkc Technologies, INC. | $29.41 | 2024 | |
| Alcon Vision LLC | $15.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neda Gioia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.